Literature DB >> 24650579

Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype.

Ana Ferro1, Bárbara Peleteiro2, Matteo Malvezzi3, Cristina Bosetti3, Paola Bertuccio3, Fabio Levi4, Eva Negri3, Carlo La Vecchia5, Nuno Lunet6.   

Abstract

Gastric cancer incidence and mortality decreased substantially over the last decades in most countries worldwide, with differences in the trends and distribution of the main topographies across regions. To monitor recent mortality trends (1980-2011) and to compute short-term predictions (2015) of gastric cancer mortality in selected countries worldwide, we analysed mortality data provided by the World Health Organization. We also analysed incidence of cardia and non-cardia cancers using data from Cancer Incidence in Five Continents (2003-2007). The joinpoint regression over the most recent calendar periods gave estimated annual percent changes (EAPC) around -3% for the European Union (EU) and major European countries, as well as in Japan and Korea, and around -2% in North America and major Latin American countries. In the United States of America (USA), EU and other major countries worldwide, the EAPC, however, were lower than in previous years. The predictions for 2015 show that a levelling off of rates is expected in the USA and a few other countries. The relative contribution of cardia and non-cardia gastric cancers to the overall number of cases varies widely, with a generally higher proportion of cardia cancers in countries with lower gastric cancer incidence and mortality rates (e.g. the USA, Canada and Denmark). Despite the favourable mortality trends worldwide, in some countries the declines are becoming less marked. There still is the need to control Helicobacter pylori infection and other risk factors, as well as to improve diagnosis and management, to further reduce the burden of gastric cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardia; Gastric neoplasms; Incidence; Mortality; Trends

Mesh:

Year:  2014        PMID: 24650579     DOI: 10.1016/j.ejca.2014.01.029

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  245 in total

1.  KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity.

Authors:  Pedro Queirós; Hugo Pinheiro; Joana Carvalho; Patrícia Oliveira; Irene Gullo; Fátima Carneiro; Gabriela M Almeida; Carla Oliveira
Journal:  Virchows Arch       Date:  2015-08-29       Impact factor: 4.064

2.  Risk Factors for Postoperative Delirium After Gastrectomy in Gastric Cancer Patients.

Authors:  Shinsaku Honda; Kenichiro Furukawa; Noriyuki Nishiwaki; Keiichi Fujiya; Hayato Omori; Sanae Kaji; Rie Makuuchi; Tomoyuki Irino; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

3.  LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.

Authors:  Jing Zhao; Peizhun Du; Peng Cui; Yunyun Qin; Cheng'en Hu; Jing Wu; Zhongwen Zhou; Wenhong Zhang; Lunxiu Qin; Guangjian Huang
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

4.  Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer.

Authors:  Xu Lu; Jingwei Liu; Peilin Cui; Tao Liu; Chunmei Piao; Xianghong Xu; Qike Zhang; Man Xiao; Xuesong Liu; Yue Wang; Lin Yang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 5.  Role of Helicobacter pylori in gastric cancer: Updates.

Authors:  Jahanarah Khatoon; Ravi Prakash Rai; Kashi Nath Prasad
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 6.  Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation.

Authors:  Jing Zhao; Yongchao Liu; Guangjian Huang; Peng Cui; Wenhong Zhang; Ying Zhang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 7.  Changing Trends in Stomach Cancer Throughout the World.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham
Journal:  Curr Gastroenterol Rep       Date:  2017-08

8.  Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer.

Authors:  Ming Bai; Peiyun Wang; Jiayu Yang; Mengsi Zuo; Yi Ba
Journal:  J Physiol Biochem       Date:  2020-07-31       Impact factor: 4.158

Review 9.  New advances in targeted gastric cancer treatment.

Authors:  Daniela Cornelia Lazăr; Sorina Tăban; Marioara Cornianu; Alexandra Faur; Adrian Goldiş
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

10.  Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.

Authors:  Haiyan Yang; Zhenguo Liu; Cuncun Yuan; Yunfei Zhao; Lei Wang; Jiong Hu; Dacheng Xie; Liwei Wang; Donghui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.